Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas

Published:2025 Issue: Volume:36 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Jamieson Amy¹^ORCID,McConechy Melissa K.²^ORCID,Lum Amy³^ORCID,Senz Janine³^ORCID,Dowhy Tanner²^ORCID,Huntsman David G.²³^ORCID,McAlpine Jessica N.¹^ORCID

Affiliation:

1. Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of British Columbia, Vancouver, Canada.

2. Imagia Canexia Health, Inc., Vancouver, Canada.

3. Department of Molecular Oncology, University of British Columbia, Vancouver, Canada.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2025.36.e5

Reference23 articles.

1. FIGO staging of endometrial cancer: 2023

2. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update

3. Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers

4. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

5. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Circulating Tumor DNA in Ovarian Cancer;Cancers;2024-09-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP